TMC125-TiDP2-C187: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Interaction Between TMC125 and Two Antifungal Agents (Fluconazole and Voriconazole), All at Steady-state in Healthy Subjects.

Clinical trial NCT00740389 · COMPLETED

Trial details

NCT number: NCT00740389
Sponsor: Tibotec Pharmaceuticals, Ireland
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

HIV AIDS Fungal Infection

Start date: 2008-09-01
Primary completion: 2009-01-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.